Found: 112
Select item for more details and to access through your institution.
Primary progressive multiple sclerosis.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Diagnostic criteria for primary progressive multiple sclerosis: a position paper.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Comparison between gadolinium-enhanced 2D T1-weighted gradient-echo and spin-echo sequences in the detection of active multiple sclerosis lesions on 3.0T MRI.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 8, p. 912, doi. 10.1177/1352458519845844
- By:
- Publication type:
- Article
Antibodies against endothelial cells in patients with multiple sclerosis.
- Published in:
- Acta Neurologica Scandinavica, 1996, v. 93, n. 6, p. 416, doi. 10.1111/j.1600-0404.1996.tb00020.x
- By:
- Publication type:
- Article
Different antiganglioside antibody pattern between relapsing-remitting and progressive multiple sclerosis.
- Published in:
- Acta Neurologica Scandinavica, 1996, v. 93, n. 2/3, p. 99, doi. 10.1111/j.1600-0404.1996.tb00182.x
- By:
- Publication type:
- Article
Metallothionein expression in the central nervous system of multiple sclerosis patients.
- Published in:
- Cellular & Molecular Life Sciences, 2003, v. 60, n. 6, p. 1258, doi. 10.1007/s00018-003-3021-z
- By:
- Publication type:
- Article
Increased demyelination and axonal damage in metallothionein I+II-deficient mice during experimental autoimmune encephalomyelitis.
- Published in:
- Cellular & Molecular Life Sciences, 2003, v. 60, n. 1, p. 185, doi. 10.1007/s000180300013
- By:
- Publication type:
- Article
Pharmacogenomic analysis of interferon receptor polymorphisms in multiple sclerosis.
- Published in:
- Genes & Immunity, 2003, v. 4, n. 2, p. 147, doi. 10.1038/sj.gene.6363946
- By:
- Publication type:
- Article
Regional cortical thinning in multiple sclerosis and its relation with cognitive impairment: A multicenter study.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 7, p. 901, doi. 10.1177/1352458515607650
- By:
- Publication type:
- Article
Expression of semaphorin 3A, semaphorin 7A and their receptors in multiple sclerosis lesions.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 13, p. 1632, doi. 10.1177/1352458515599848
- By:
- Publication type:
- Article
Brain atrophy in natalizumab-treated patients: A 3-year follow-up.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 6, p. 749, doi. 10.1177/1352458514556300
- By:
- Publication type:
- Article
Significant clinical worsening after natalizumab withdrawal: Predictive factors.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 6, p. 780, doi. 10.1177/1352458514549401
- By:
- Publication type:
- Article
Five-year results from a phase 2 study of oral fingolimod in relapsing multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 7, p. 877, doi. 10.1177/1352458513513059
- By:
- Publication type:
- Article
A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 6, p. 717, doi. 10.1177/1352458513508835
- By:
- Publication type:
- Article
Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 5, p. 577, doi. 10.1177/1352458513503597
- By:
- Publication type:
- Article
Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 1, p. 72, doi. 10.1177/1352458513492245
- By:
- Publication type:
- Article
Clinical impact of early brain atrophy in clinically isolated syndromes.
- Published in:
- Multiple Sclerosis Journal, 2013, v. 19, n. 14, p. 1878, doi. 10.1177/1352458513488231
- By:
- Publication type:
- Article
Scoring treatment response in patients with relapsing multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2013, v. 19, n. 5, p. 605, doi. 10.1177/1352458512460605
- By:
- Publication type:
- Article
SIGLEC1 and SIGLEC7 expression in circulating monocytes of patients with multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2013, v. 19, n. 5, p. 524, doi. 10.1177/1352458512458718
- By:
- Publication type:
- Article
Increase in the prevalence of multiple sclerosis over a 17-year period in Osona, Catalonia, Spain.
- Published in:
- Multiple Sclerosis Journal, 2013, v. 19, n. 2, p. 245, doi. 10.1177/1352458512444751
- By:
- Publication type:
- Article
Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 7, p. 983, doi. 10.1177/1352458511433063
- By:
- Publication type:
- Article
Predictive nature of IgM anti-α-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysis.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 7, p. 966, doi. 10.1177/1352458511432327
- By:
- Publication type:
- Article
Oral fingolimod (FTY720) in relapsing multiple sclerosis: impact on health-related quality of life in a phase II study.
- Published in:
- Multiple Sclerosis Journal, 2011, v. 17, n. 11, p. 1341, doi. 10.1177/1352458511411061
- By:
- Publication type:
- Article
A functional magnetic resonance proof of concept pilot trial of cognitive rehabilitation in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2011, v. 17, n. 4, p. 457, doi. 10.1177/1352458510389219
- By:
- Publication type:
- Article
Four-year safety and effectiveness data from patients with multiple sclerosis treated with fingolimod: The Spanish GILENYA registry.
- Published in:
- PLoS ONE, 2021, v. 16, n. 10, p. 1, doi. 10.1371/journal.pone.0258437
- By:
- Publication type:
- Article
The ACROSS study: Long-term efficacy of fingolimod in patients with relapsing--remitting multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2020, v. 6, p. 1, doi. 10.1177/2055217320907951
- By:
- Publication type:
- Article
Effectiveness of delayed-release dimethyl fumarate on patient-reported outcomes and clinical measures in patients with relapsing–remitting multiple sclerosis in a real-world clinical setting: PROTEC.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2019, v. 5, n. 4, p. 1, doi. 10.1177/2055217319887191
- By:
- Publication type:
- Article
Lesion filling effect in regional brain volume estimations: a study in multiple sclerosis patients with low lesion load.
- Published in:
- Neuroradiology, 2016, v. 58, n. 5, p. 467, doi. 10.1007/s00234-016-1654-5
- By:
- Publication type:
- Article
The basal ganglia: a substrate for fatigue in multiple sclerosis.
- Published in:
- Neuroradiology, 2008, v. 50, n. 1, p. 17, doi. 10.1007/s00234-007-0304-3
- By:
- Publication type:
- Article
APS and the brain.
- Published in:
- Lupus, 2003, v. 12, n. 12, p. 877, doi. 10.1191/0961203303lu496oa
- By:
- Publication type:
- Article
Natalizumab treatment of multiple sclerosis in Spain: results of an extensive observational study.
- Published in:
- Journal of Neurology, 2012, v. 259, n. 9, p. 1814, doi. 10.1007/s00415-012-6414-9
- By:
- Publication type:
- Article
A search for new MRI criteria for dissemination in space in subjects with a clinically isolated syndrome.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonb therapy in multiple sclerosis.
- Published in:
- Genes & Immunity, 2012, v. 13, n. 5, p. 443, doi. 10.1038/gene.2012.18
- By:
- Publication type:
- Article
ANKRD55 and DHCR7 are novel multiple sclerosis risk loci.
- Published in:
- Genes & Immunity, 2012, v. 13, n. 3, p. 253, doi. 10.1038/gene.2011.81
- By:
- Publication type:
- Article
A cytokine gene screen uncovers SOCS1 as genetic risk factor for multiple sclerosis.
- Published in:
- Genes & Immunity, 2012, v. 13, n. 1, p. 21, doi. 10.1038/gene.2011.44
- By:
- Publication type:
- Article
Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonβ therapy in multiple sclerosis.
- Published in:
- Genes & Immunity, 2011, v. 12, n. 6, p. 466, doi. 10.1038/gene.2011.18
- By:
- Publication type:
- Article
Replication of top markers of a genome-wide association study in multiple sclerosis in Spain.
- Published in:
- Genes & Immunity, 2011, v. 12, n. 2, p. 110, doi. 10.1038/gene.2010.52
- By:
- Publication type:
- Article
Gut dysbiosis and neuroimmune responses to brain infection with Theiler's murine encephalomyelitis virus.
- Published in:
- Scientific Reports, 2017, p. 44377, doi. 10.1038/srep44377
- By:
- Publication type:
- Article
Interferon beta‐1b treatment in patients with relapsing–remitting multiple sclerosis under a standardized protocol in Spain.
- Published in:
- Acta Neurologica Scandinavica, 2000, v. 102, n. 4, p. 209, doi. 10.1034/j.1600-0404.2000.102004209.x
- By:
- Publication type:
- Article
Primary progressive multiple sclerosis.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Anti-myelin antibodies play an important role in the susceptibility to develop proteolipid protein-induced experimental autoimmune encephalomyelitis.
- Published in:
- Clinical & Experimental Immunology, 2014, v. 175, n. 2, p. 202, doi. 10.1111/cei.12233
- By:
- Publication type:
- Article
Cellular immune responses in multiple sclerosis patients treated with interferon-beta.
- Published in:
- Clinical & Experimental Immunology, 2013, v. 171, n. 3, p. 243, doi. 10.1111/cei.12016
- By:
- Publication type:
- Article
Role of tumour necrosis factor (TNF)-α and TNFRSF1 A R92Q mutation in the pathogenesis of TNF receptor-associated periodic syndrome and multiple sclerosis.
- Published in:
- Clinical & Experimental Immunology, 2011, v. 166, n. 3, p. 338, doi. 10.1111/j.1365-2249.2011.04484.x
- By:
- Publication type:
- Article
Treatment with methylprednisolone in relapses of multiple sclerosis patients: immunological evidence of immediate and short-term but not long-lasting effects.
- Published in:
- Clinical & Experimental Immunology, 2002, v. 127, n. 1, p. 165, doi. 10.1046/j.1365-2249.2002.01725.x
- By:
- Publication type:
- Article
Peptide T does not ameliorate experimental autoimmune encephalomyelitis (EAE) in Lewis rats.
- Published in:
- Clinical & Experimental Immunology, 2000, v. 121, n. 1, p. 151, doi. 10.1046/j.1365-2249.2000.01259.x
- By:
- Publication type:
- Article
MRI criteria for MS in patients with clinically isolated syndromes.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
A type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosis.
- Published in:
- 2009
- By:
- Publication type:
- journal article
A type I interferon signature in monocytes is associated with poor response to interferon-β in multiple sclerosis.
- Published in:
- Brain: A Journal of Neurology, 2009, v. 132, n. 12, p. 3353, doi. 10.1093/brain/awp228
- By:
- Publication type:
- Article